Cancer diagnoses in England hit record high of more than 1,000 people a day

England recorded more than 373,000 cancer diagnoses in 2024, the highest number ever recorded. That equals an average of 1,021 diagnoses each day. The figure matters because it shows the scale of demand facing NHS cancer services.

The comparison with 2023 is based on the daily average: NHS England diagnosed 972 people per day then. The increase was therefore 49 diagnoses per day, although the article does not give the total number diagnosed in 2023.

A record number does not automatically mean care is improving. More diagnoses can reflect better detection and more people being checked, while services may still struggle to diagnose and treat patients quickly. In 2024, 56.7% of first new cancers were found at stages 1 or 2, up from 55.8% in 2023, but waiting-time targets were still missed.

Cancer stages describe how far a cancer has developed when it is found. In general, stage 1 means a smaller, more localised cancer, while stage 2 usually means a larger tumour or limited spread into nearby tissue or lymph nodes. Exact definitions vary by cancer type, so staging is not identical for every tumour.

Earlier diagnosis usually matters because treatment can begin before cancer spreads extensively. Localised cancers may offer more treatment choices and a better chance of successful control or cure. This is a general medical principle, not a guarantee for every patient.

The English figures show modest progress. In 2024, 56.7% of first new cancers were diagnosed at stages 1 or 2, compared with 55.8% in 2023. Yet Dr Ian Walker warned that too many cancers were still found late, showing why faster diagnosis and targeted screening remain important.

Prostate, breast, lung and bowel cancers accounted for half of all new diagnoses in England. This concentration matters because pressure on cancer services is shaped heavily by a few high-volume diseases, not only by the total number of cancers.

These cancers are common for different reasons. Risk generally rises with age, and England has an ageing population. Obesity is a recognised risk factor for several cancers, as Dr Hilary Williams noted. Inherited susceptibility, smoking, alcohol, infections and other exposures also influence risk, but the article does not give separate explanations or figures for each cancer type.

The practical response must combine prevention, early detection and treatment capacity. The article highlights targeted lung-cancer screening and breast-awareness advice. It also stresses that people should attend eligible breast-screening appointments and report new or unusual changes promptly to a GP.

The NHS has two important cancer waiting-time targets. At least 80% of patients urgently referred for suspected cancer should receive a diagnosis or have cancer ruled out within 28 days. At least 85% should begin treatment within 62 days of an urgent referral or consultant upgrade.

The latest monthly figures, for August, show the scale of the gap. The 28-day result was 78.6%, which was 1.4 percentage points below target. The 62-day treatment result was 71.9%, 13.1 percentage points below its target. These are percentage-point differences, not percentages of the target missed.

The figures suggest treatment delays are more severe than diagnostic delays. NHS England is finding more cancers and slightly improving early-stage diagnosis, but patients can still wait too long afterward. The government’s cancer plan and calls for specialist staff, equipment and accountability are intended to improve this performance.

A rising diagnosis count and poor waiting-time performance measure different things. The first counts how many cancers are found. The second measures how quickly patients move through diagnosis and treatment. One can rise while the other worsens if demand grows faster than available services.

The article gives several pressures behind higher demand. England has an ageing population, and obesity is also a major cancer risk factor. NHS teams are taking tests and checks closer to people, which can help identify more cases. More diagnoses may therefore reflect improved detection as well as a larger workload.

That workload can expose shortages in specialist staff, equipment and treatment capacity. In August, 78.6% met the 28-day standard and only 71.9% met the 62-day treatment standard. The article calls for focused government effort, clear accountability and stronger NHS support so increased detection is matched by timely care.

Screening checks people who may not yet have symptoms. Its purpose is to spot warning signs or early cancers before they become harder to treat. Earlier detection can increase treatment options and improve outcomes, although screening cannot prevent every cancer or guarantee a cure.

Breast screening can identify changes that need assessment, while targeted lung-cancer screening focuses checks on people with a higher risk. The article also urges women to attend breast-screening appointments when invited and to report new or unusual breast changes to a GP. These routes can bring diagnosis forward.

The 2024 figures show why this matters: 56.7% of first new cancers were diagnosed at stages 1 or 2, up from 55.8% in 2023. Dr Hilary Williams called for targeted lung screening to expand. Screening must be matched with enough staff and equipment to investigate results and treat cancers promptly.

Cancer is a group of diseases in which abnormal cells grow and divide without normal control. These cells can invade nearby tissue and, in some cancers, spread elsewhere. This biological explanation comes from established medical knowledge; the article itself focuses on diagnosis, risk and NHS capacity rather than defining cancer.

Risk usually builds through changes in cells over time. Ageing gives more opportunity for such changes to accumulate. Inherited gene changes can raise susceptibility, while obesity can alter biological processes linked with several cancers. Smoking, alcohol, infections, radiation and other environmental or lifestyle factors can also contribute, depending on the cancer type.

The article specifically identifies ageing and obesity as important influences on rising diagnoses. It also calls for prevention, earlier detection and better specialist support. Risk factors increase probability rather than determine an individual’s future, so people without obvious risks can still develop cancer and people with risks may not develop it.